首页 > 最新文献

Intelligent Pharmacy最新文献

英文 中文
Synthesis of 1,3-substituted 1H-indazole derivatives and evaluation of anti-inflammatory activity in Sprague Dawley rats 1,3-取代的 1H-indazole 衍生物的合成及对 Sprague Dawley 大鼠抗炎活性的评估
Pub Date : 2024-02-01 DOI: 10.1016/j.ipha.2023.09.009
Vishal Kumar , Anup Kumar Sirbaiya , Md Nematullah , Md Faheem Haider , Md Azizur Rahman

Indazole is a very significant group of heterocyclics. Aim of the research was thus planned to synthesize novel derivatives of indazole and evaluate their anti-inflammatory activity. Novel compounds of indazole were first synthesized from reaction of 2-chlorobenzonitrile with phenylhydrazine in presence of catalyst potassium t-butoxide (t-BuOK) and the solvent diglyme. Synthesized derivatives of indazole were analyzed by 1H-NMR and MS spectroscopic techniques. All the synthesized derivatives of indazole were evaluated for their anti-inflammatory activity in Sprague Dawley rats by carrageenan-induced rat paw edema method. All the synthesized derivatives of indazole had shown very good activity in both docking and anti-inflammatory activity in rats in comparison to the standard etoricoxib. Compound 1a in a dose of 30 ​mg/kg body weight had shown most significant inhibition of edema as compared to toxic group and the inhibition was comparable to that of the standard drug, etoricoxib in a dose of 10 ​mg/kg body weight. A convenient means for the synthesis of derivatives of indazole was developed which may find applications in heterocyclic synthesis of derivatives of indazole. Compound 1a i.e., 3-(4-carboxyphenyl)amino-1-phenyl-1H-indazole had shown best anti-inflammatory activity amongst all the synthesized compounds.

吲唑是一类非常重要的杂环化合物。因此,本研究计划合成吲唑的新型衍生物,并评估其抗炎活性。首先,在催化剂叔丁氧钾(t-BuOK)和溶剂二甘醇的作用下,将 2-氯苯腈与苯肼反应,合成了新型吲唑化合物。合成的吲唑衍生物通过 1H-NMR 和 MS 光谱技术进行分析。用卡拉胶诱导的大鼠爪水肿法评估了所有合成的吲唑衍生物对 Sprague Dawley 大鼠的抗炎活性。与标准药物依托考昔(etoricoxib)相比,所有合成的吲唑衍生物在大鼠的对接和抗炎活性方面都表现出了很好的活性。与毒性组相比,剂量为 30 毫克/千克体重的化合物 1a 对水肿的抑制作用最为显著,其抑制作用与剂量为 10 毫克/千克体重的标准药物依托考昔相当。研究人员开发出了一种合成吲唑衍生物的简便方法,可用于吲唑衍生物的杂环合成。在所有合成的化合物中,化合物 1a 即 3-(4-羧基苯基)氨基-1-苯基-1H-吲唑显示出最佳的抗炎活性。
{"title":"Synthesis of 1,3-substituted 1H-indazole derivatives and evaluation of anti-inflammatory activity in Sprague Dawley rats","authors":"Vishal Kumar ,&nbsp;Anup Kumar Sirbaiya ,&nbsp;Md Nematullah ,&nbsp;Md Faheem Haider ,&nbsp;Md Azizur Rahman","doi":"10.1016/j.ipha.2023.09.009","DOIUrl":"10.1016/j.ipha.2023.09.009","url":null,"abstract":"<div><p>Indazole is a very significant group of heterocyclics. Aim of the research was thus planned to synthesize novel derivatives of indazole and evaluate their anti-inflammatory activity. Novel compounds of indazole were first synthesized from reaction of 2-chlorobenzonitrile with phenylhydrazine in presence of catalyst potassium <em>t</em>-butoxide (<em>t</em>-BuOK) and the solvent diglyme. Synthesized derivatives of indazole were analyzed by <sup>1</sup><em>H</em>-NMR and MS spectroscopic techniques. All the synthesized derivatives of indazole were evaluated for their anti-inflammatory activity in Sprague Dawley rats by carrageenan-induced rat paw edema method. All the synthesized derivatives of indazole had shown very good activity in both docking and anti-inflammatory activity in rats in comparison to the standard etoricoxib. Compound <strong>1a</strong> in a dose of 30 ​mg/kg body weight had shown most significant inhibition of edema as compared to toxic group and the inhibition was comparable to that of the standard drug, etoricoxib in a dose of 10 ​mg/kg body weight. A convenient means for the synthesis of derivatives of indazole was developed which may find applications in heterocyclic synthesis of derivatives of indazole. Compound <strong>1a</strong> i.e., 3-(4-carboxyphenyl)amino-1-phenyl-1<em>H</em>-indazole had shown best anti-inflammatory activity amongst all the synthesized compounds.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 1","pages":"Pages 40-44"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23000850/pdfft?md5=e235c2bc500cfb3fbfb7fb05fea4f757&pid=1-s2.0-S2949866X23000850-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134918285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in anti-dengue drug development 人工智能在抗登革热药物开发中的应用
Pub Date : 2024-02-01 DOI: 10.1016/j.ipha.2024.01.006
M. Roney
{"title":"Artificial intelligence in anti-dengue drug development","authors":"M. Roney","doi":"10.1016/j.ipha.2024.01.006","DOIUrl":"https://doi.org/10.1016/j.ipha.2024.01.006","url":null,"abstract":"","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"21 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139880603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in anticancer approach of traditional medicinal plants: A novel strategy for cancer chemotherapy 传统药用植物抗癌方法的最新进展:癌症化疗的新策略
Pub Date : 2024-02-01 DOI: 10.1016/j.ipha.2024.02.001
Priyanka Bajpai, S. Usmani, Rakesh Kumar, Om Prakash
{"title":"Recent advances in anticancer approach of traditional medicinal plants: A novel strategy for cancer chemotherapy","authors":"Priyanka Bajpai, S. Usmani, Rakesh Kumar, Om Prakash","doi":"10.1016/j.ipha.2024.02.001","DOIUrl":"https://doi.org/10.1016/j.ipha.2024.02.001","url":null,"abstract":"","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"69 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139873111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aceclofenac loaded microspheres: Formulation and evaluation of novel preprogrammed drug delivery for the treatment of arthritis 醋氯芬酸负载微球:用于治疗关节炎的新型预编程给药的制备与评估
Pub Date : 2024-02-01 DOI: 10.1016/j.ipha.2023.10.010
Hema Jaiswal , Mohammad Tahir Ansari , Tarique Mahmood , Farogh Ahsan , Vaseem Ahamad Ansari , Usama Ahmad

Arthritis is a widespread joint disorder globally, the patient completely dependent on NSAIDs which are administered after a fixed interval to subside the pain. This work aims to establish a preprogrammed drug delivery system of aceclofenac with a predetermined lag time for the treatment of arthritis. This new preprogrammed formulation microsphere reduces the time-dependent dose administration as it steadily releases the drug in the blood circulation reducing side effects and increasing patient compliance. Aceclofenac (ACF) loaded polymer microspheres were prepared by a new emulsification and crosslinking method using glutaraldehyde as cross-linking agent. Microspheres were prepared in 6 batches using different polymers like sodium alginate, guar gum and chitosan, alone, as well as in combinations. The type and quantity of polymers were changed in every batch while the amount of aceclofenac was unvarying. The microspheres were then evaluated for the particle size, drug content, percentage yield, percentage entrapment efficiency and percentage drug release followed by noting the lag time. The microsphere loaded with aceclofenac were formulated and evaluated, the result showed that all the preparations showed a good lag time (2–3 ​h), but chitosan (alone) gave the highest lag time, which fulfills the aim of pre-programmed drug delivery system. Preprogrammed drug release has been achieved from the microspheres over a period of 0–7 ​h, consistent with the demand for chronotherapeutic drug delivery for the treatment of arthritis. The major signification of the preparation technique includes short processing time and the lack of exposure of the ingredients to high temperatures. Aceclofenac-loaded microspheres offer a promising avenue for arthritis treatment, ensuring sustained drug release. Their potential clinical implications include enhanced therapeutic efficacy, reduced side effects, and improved patient compliance. Future directions may involve personalized formulations, targeted delivery systems, and exploring applications beyond arthritis, expanding the scope of this innovative drug delivery approach.

关节炎是全球广泛存在的一种关节疾病,患者完全依赖非甾体抗炎药物在固定时间间隔后给药来缓解疼痛。这项研究旨在建立一种具有预定滞后时间的醋氯芬酸预编程给药系统,用于治疗关节炎。这种新的预编程配方微球减少了剂量给药的时间依赖性,因为它能在血液循环中稳定释放药物,从而减少副作用并提高患者的依从性。使用戊二醛作为交联剂,通过一种新的乳化和交联方法制备了负载醋氯芬酸(ACF)的聚合物微球。使用海藻酸钠、瓜尔豆胶和壳聚糖等不同聚合物单独或组合制备了 6 批微球。每批聚合物的类型和数量都有所变化,而醋氯芬酸的用量则保持不变。然后对微球的粒度、药物含量、产量百分比、夹持效率百分比和药物释放百分比进行评估,并记录滞后时间。结果表明,所有制剂都显示出良好的滞后时间(2-3 小时),但壳聚糖(单独)的滞后时间最长,达到了预编程给药系统的目的。微球在 0-7 小时内实现了预编程药物释放,符合治疗关节炎的时程给药需求。这种制备技术的主要特点是加工时间短,成分无需暴露在高温下。装载醋氯芬酸的微球为关节炎治疗提供了一种前景广阔的途径,可确保药物的持续释放。其潜在的临床意义包括提高疗效、减少副作用和改善患者的依从性。未来的发展方向可能包括个性化配方、靶向给药系统以及探索关节炎以外的应用,从而扩大这种创新给药方法的应用范围。
{"title":"Aceclofenac loaded microspheres: Formulation and evaluation of novel preprogrammed drug delivery for the treatment of arthritis","authors":"Hema Jaiswal ,&nbsp;Mohammad Tahir Ansari ,&nbsp;Tarique Mahmood ,&nbsp;Farogh Ahsan ,&nbsp;Vaseem Ahamad Ansari ,&nbsp;Usama Ahmad","doi":"10.1016/j.ipha.2023.10.010","DOIUrl":"10.1016/j.ipha.2023.10.010","url":null,"abstract":"<div><p>Arthritis is a widespread joint disorder globally, the patient completely dependent on NSAIDs which are administered after a fixed interval to subside the pain. This work aims to establish a preprogrammed drug delivery system of aceclofenac with a predetermined lag time for the treatment of arthritis. This new preprogrammed formulation microsphere reduces the time-dependent dose administration as it steadily releases the drug in the blood circulation reducing side effects and increasing patient compliance. Aceclofenac (ACF) loaded polymer microspheres were prepared by a new emulsification and crosslinking method using glutaraldehyde as cross-linking agent. Microspheres were prepared in 6 batches using different polymers like sodium alginate, guar gum and chitosan, alone, as well as in combinations. The type and quantity of polymers were changed in every batch while the amount of aceclofenac was unvarying. The microspheres were then evaluated for the particle size, drug content, percentage yield, percentage entrapment efficiency and percentage drug release followed by noting the lag time. The microsphere loaded with aceclofenac were formulated and evaluated, the result showed that all the preparations showed a good lag time (2–3 ​h), but chitosan (alone) gave the highest lag time, which fulfills the aim of pre-programmed drug delivery system. Preprogrammed drug release has been achieved from the microspheres over a period of 0–7 ​h, consistent with the demand for chronotherapeutic drug delivery for the treatment of arthritis. The major signification of the preparation technique includes short processing time and the lack of exposure of the ingredients to high temperatures. Aceclofenac-loaded microspheres offer a promising avenue for arthritis treatment, ensuring sustained drug release. Their potential clinical implications include enhanced therapeutic efficacy, reduced side effects, and improved patient compliance. Future directions may involve personalized formulations, targeted delivery systems, and exploring applications beyond arthritis, expanding the scope of this innovative drug delivery approach.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 1","pages":"Pages 69-82"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23001016/pdfft?md5=2acb88de8cb2027b64b4d3858b16868f&pid=1-s2.0-S2949866X23001016-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135372139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An aqueous extract of Syzygium cumini bark reduces the rate of preterm birth in rats 茜草树皮水提取物可降低大鼠的早产率
Pub Date : 2024-02-01 DOI: 10.1016/j.ipha.2023.09.004
M. Ramasamy , Karthikeyan E

Preterm delivery is a considerable burden on prenatal healthcare and a major risk factor for neurological impairment and disability. A study looked at whether an aqueous extract of Syzygium cumini (AESC) bark could stop rats from giving birth too early. The DPPH and ABTS radical scavenging assays were used to evaluate the antioxidant activity of AESC in vitro, and the results showed that this extract possesses free radical scavenging activity, which helps to prevent premature labour. A piece of an isolated rat uterus was used for in-vitro pharmacological testing of the AESC at 25 ​mg/ml and 50 ​mg/ml. The extract showed free radical scavenging activity, effectively suppressing uterine contractions by 45.7% and 66.9%, respectively. The researchers concluded that AESC has considerable tocolytic activity, resulting in a decrease in the rate of premature birth. The extract showed no significant adverse effects on mothers or their infants, suggesting it may be a safe option for pregnant individuals seeking to prevent preterm labor. The extract also exhibited a dose-dependent effect, with higher doses resulting in a greater reduction in premature birth rates, further supporting its efficacy as a tocolytic agent.

早产是产前保健的一大负担,也是导致神经损伤和残疾的主要风险因素。一项研究探讨了茜草树皮水提取物(AESC)能否阻止大鼠过早分娩。研究采用 DPPH 和 ABTS 自由基清除试验来评估 AESC 在体外的抗氧化活性,结果表明这种提取物具有清除自由基的活性,有助于防止早产。使用一片离体大鼠子宫对 25 毫克/毫升和 50 毫克/毫升的 AESC 进行体外药理测试。该提取物具有清除自由基的活性,可有效抑制子宫收缩,抑制率分别为 45.7% 和 66.9%。研究人员认为,AESC 具有相当强的溶血活性,可降低早产率。该提取物对母亲或婴儿没有明显的不良影响,这表明它可能是孕妇预防早产的一个安全选择。该提取物还表现出剂量依赖效应,剂量越大,早产率下降越多,这进一步证明了它作为溶血剂的功效。
{"title":"An aqueous extract of Syzygium cumini bark reduces the rate of preterm birth in rats","authors":"M. Ramasamy ,&nbsp;Karthikeyan E","doi":"10.1016/j.ipha.2023.09.004","DOIUrl":"10.1016/j.ipha.2023.09.004","url":null,"abstract":"<div><p>Preterm delivery is a considerable burden on prenatal healthcare and a major risk factor for neurological impairment and disability. A study looked at whether an aqueous extract of <em>Syzygium cumini</em> (AESC) bark could stop rats from giving birth too early. The DPPH and ABTS radical scavenging assays were used to evaluate the antioxidant activity of AESC in vitro, and the results showed that this extract possesses free radical scavenging activity, which helps to prevent premature labour. A piece of an isolated rat uterus was used for in-vitro pharmacological testing of the AESC at 25 ​mg/ml and 50 ​mg/ml. The extract showed free radical scavenging activity, effectively suppressing uterine contractions by 45.7% and 66.9%, respectively. The researchers concluded that AESC has considerable tocolytic activity, resulting in a decrease in the rate of premature birth. The extract showed no significant adverse effects on mothers or their infants, suggesting it may be a safe option for pregnant individuals seeking to prevent preterm labor. The extract also exhibited a dose-dependent effect, with higher doses resulting in a greater reduction in premature birth rates, further supporting its efficacy as a tocolytic agent.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 1","pages":"Pages 136-143"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23000801/pdfft?md5=b4d65d8a3c779869f3e5e52ac804bd50&pid=1-s2.0-S2949866X23000801-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135433951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting SARS-CoV-2 main protease (Mpro) and human ACE-2: A virtual screening of carotenoids and polyphenols from tomato (Solanum lycopersicum L.) to combat Covid-19 以 SARS-CoV-2 主要蛋白酶 (Mpro) 和人类 ACE-2 为靶标:虚拟筛选番茄(Solanum lycopersicum L.)中的类胡萝卜素和多酚类化合物以对抗 Covid-19
Pub Date : 2024-02-01 DOI: 10.1016/j.ipha.2023.10.008
Parvej Ahmad , Sahir Sultan Alvi , Inamul Hasan , M. Salman Khan

Background

Human angiotensin-converting enzyme-2 (ACE-2) and severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) main protease (Mpro) have been established as the prime targets to restrict viral invasion and replication inside the host, respectively.

Methods

The current study delineated the SARS-CoV-2 Mpro as well as human ACE-2 inhibitory potential of carotenoids and polyphenols from tomato (Solanum lycopersicum L.) via in-silico interaction studies.

Results

Our drug-likeness studies showed that the selected carotenoids and polyphenols exhibited acceptable Lipinski’s score and ADME determinants. Further, in-silico molecular modelling studies revealed that β-carotene, among other carotenoids, topped the binding score (ΔG: −6.75 ​kcal/mol; Ki: 11.32 ​μM) against SARS-CoV-2 Mpro, whereas, cyanidin was the best inhibitor of SARS-CoV-2 Mpro (−7.24 ​kcal/mol; Ki: 4.92 ​μM) amongst polyphenols. Similarly, α-carotene from carotenoids exhibited strongest human ACE-2 inhibitory activity (ΔG: −8.85 ​kcal/mol; Ki: 326.13 ​μM), whereas, cyanidin from polyphenols showed best binding affinity against human ACE-2 (ΔG: −7.24 ​kcal/mol; Ki: 4.89 ​μM). In contrast, 6-(ethylamino)-pyridine-3-carbonitrile, standard inhibitor of SARS-CoV-2 Mpro, exhibited comparatively weaker binding (ΔG: −4.78 ​kcal/mol; Ki: 267.49 ​μM), whereas, telmisartan (reference ACE-2 inhibitor) also exhibited lesser affinity (ΔG: −6.40 ​kcal/mol; Ki: 20.40 ​μM). Further exploration via MDS studies also validated the dynamic behavior and stability of protein-ligand complexes as evident by desirable RMSD, RMSF, Rg, and SASA.

Conclusion

The current study established carotenoids and polyphenols from S. lycopersicum L. as finer substitutes of reference standards against SARS-CoV-2 Mpro and human ACE-2 activity in combating SARS-CoV-2 infection.

背景人类血管紧张素转换酶-2(ACE-2)和严重急性呼吸系统综合征冠状病毒-2(SARS-CoV-2)主蛋白酶(Mpro)已被确定为限制病毒入侵和在宿主体内复制的主要靶标。结果我们的药物相似性研究表明,所选择的类胡萝卜素和多酚表现出了可接受的 Lipinski 评分和 ADME 决定因素。此外,硅内分子建模研究显示,在其他类胡萝卜素中,β-胡萝卜素对 SARS-CoV-2 Mpro 的结合得分最高(ΔG:-6.75 kcal/mol;Ki:11.32 μM),而在多酚类化合物中,青花素对 SARS-CoV-2 Mpro 的抑制作用最好(-7.24 kcal/mol;Ki:4.92 μM)。同样,类胡萝卜素中的α-胡萝卜素对人类 ACE-2 的抑制活性最强(ΔG:-8.85 kcal/mol;Ki:326.13 μM),而多酚中的青花素对人类 ACE-2 的结合亲和力最好(ΔG:-7.24 kcal/mol;Ki:4.89 μM)。相比之下,SARS-CoV-2 Mpro 的标准抑制剂 6-(乙基氨基)-吡啶-3-甲腈的结合力相对较弱(ΔG:-4.78 kcal/mol;Ki:267.49 μM),而替米沙坦(参考 ACE-2 抑制剂)也表现出较低的亲和力(ΔG:-6.40 kcal/mol;Ki:20.40 μM)。通过 MDS 研究进行的进一步探索还验证了蛋白质配体复合物的动态行为和稳定性,理想的 RMSD、RMSF、Rg 和 SASA 都证明了这一点。
{"title":"Targeting SARS-CoV-2 main protease (Mpro) and human ACE-2: A virtual screening of carotenoids and polyphenols from tomato (Solanum lycopersicum L.) to combat Covid-19","authors":"Parvej Ahmad ,&nbsp;Sahir Sultan Alvi ,&nbsp;Inamul Hasan ,&nbsp;M. Salman Khan","doi":"10.1016/j.ipha.2023.10.008","DOIUrl":"10.1016/j.ipha.2023.10.008","url":null,"abstract":"<div><h3>Background</h3><p>Human angiotensin-converting enzyme-2 (ACE-2) and severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) main protease (M<sup>pro</sup>) have been established as the prime targets to restrict viral invasion and replication inside the host, respectively.</p></div><div><h3>Methods</h3><p>The current study delineated the SARS-CoV-2 M<sup>pro</sup> as well as human ACE-2 inhibitory potential of carotenoids and polyphenols from tomato (<em>Solanum lycopersicum</em> L.) via <em>in-silico</em> interaction studies.</p></div><div><h3>Results</h3><p>Our drug-likeness studies showed that the selected carotenoids and polyphenols exhibited acceptable Lipinski’s score and ADME determinants. Further, i<em>n-silico</em> molecular modelling studies revealed that β-carotene, among other carotenoids, topped the binding score (ΔG: −6.75 ​kcal/mol; K<em>i</em>: 11.32 ​μM) against SARS-CoV-2 M<sup>pro</sup>, whereas, cyanidin was the best inhibitor of SARS-CoV-2 M<sup>pro</sup> (−7.24 ​kcal/mol; K<em>i</em>: 4.92 ​μM) amongst polyphenols. Similarly, α-carotene from carotenoids exhibited strongest human ACE-2 inhibitory activity (ΔG: −8.85 ​kcal/mol; K<em>i</em>: 326.13 ​μM), whereas, cyanidin from polyphenols showed best binding affinity against human ACE-2 (ΔG: −7.24 ​kcal/mol; K<em>i</em>: 4.89 ​μM). In contrast, 6-(ethylamino)-pyridine-3-carbonitrile, standard inhibitor of SARS-CoV-2 M<sup>pro</sup>, exhibited comparatively weaker binding (ΔG: −4.78 ​kcal/mol; K<em>i</em>: 267.49 ​μM), whereas, telmisartan (reference ACE-2 inhibitor) also exhibited lesser affinity (ΔG: −6.40 ​kcal/mol; K<em>i</em>: 20.40 ​μM). Further exploration via MDS studies also validated the dynamic behavior and stability of protein-ligand complexes as evident by desirable RMSD, RMSF, Rg, and SASA.</p></div><div><h3>Conclusion</h3><p>The current study established carotenoids and polyphenols from <em>S. lycopersicum</em> L. as finer substitutes of reference standards against SARS-CoV-2 M<sup>pro</sup> and human ACE-2 activity in combating SARS-CoV-2 infection.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 1","pages":"Pages 51-68"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23000990/pdfft?md5=1f5af69ec4a7f39b64b5e5511912de3d&pid=1-s2.0-S2949866X23000990-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136056562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ziziphus mauritiana: An in-depth review of its medicinal attributes and pharmacological activities 毛蕊花对其药用特性和药理活性的深入研究
Pub Date : 2023-12-12 DOI: 10.1016/j.ipha.2023.12.001
Deepak Jha , Pallavi Hangargekar , Md Akbar , Ashish Singh Parihar , Saurabh Kashyap , Amol Joshi , Md Azizur Rahman

The plant species Ziziphus mauritiana, recognized by its common name Indian jujube, is classified within the Rhamnaceae family. It has been widely used in traditional medicine for its therapeutic properties, including the treatment of asthma, anxiety, depression, fever, inflammation, and ulcers. Z. mauritiana parts, such as leaves and fruits, have been traditionally used to treat diarrhea, wounds, abscesses, swelling, gonorrhea, liver diseases, and asthma. Z. mauritiana fruits are widely recognized and valued for their nutritional and nutraceutical properties and are consumed in various forms such as dried, candied, pickled, and juice. The plant exhibits antioxidant activity, and extracts from its fruits, leaves, and seeds have shown promising results in terms of their antioxidant and anticancer activities. Phytochemical studies have identified various compounds in Z. mauritiana, including cyclopeptide alkaloids and lupane and ceanothane triterpenes. This review presents a comprehensive overview of the ethnobotanical uses, traditional medicinal uses, and phytochemical profile of Z. mauritiana, highlighting its potential as a valuable medicinal plant. Further research is warranted to explore its therapeutic potential and develop new pharmaceutical applications based on its bioactive compounds.

印度枣(Ziziphus mauritiana)是鼠李科(Rhamnaceae)植物,俗名 "印度枣"。它因其治疗特性,包括治疗哮喘、焦虑、抑郁、发烧、炎症和溃疡,而被广泛应用于传统医学中。Z. mauritiana 的叶片和果实等部分传统上用于治疗腹泻、伤口、脓肿、肿胀、淋病、肝病和哮喘。Z. mauritiana 果实因其营养和保健特性而被广泛认可和重视,并以各种形式食用,如干燥、蜜饯、腌制和榨汁。该植物具有抗氧化活性,从其果实、叶片和种子中提取的提取物在抗氧化和抗癌活性方面显示出良好的效果。植物化学研究发现了毛蕊花属植物的多种化合物,包括环肽生物碱、羽扇豆烷和芹菜烷三萜类化合物。本综述全面概述了毛果芸香科植物的民族植物学用途、传统药用和植物化学特征,强调了其作为一种珍贵药用植物的潜力。为探索其治疗潜力并开发基于其生物活性化合物的新医药应用,我们有必要开展进一步的研究。
{"title":"Ziziphus mauritiana: An in-depth review of its medicinal attributes and pharmacological activities","authors":"Deepak Jha ,&nbsp;Pallavi Hangargekar ,&nbsp;Md Akbar ,&nbsp;Ashish Singh Parihar ,&nbsp;Saurabh Kashyap ,&nbsp;Amol Joshi ,&nbsp;Md Azizur Rahman","doi":"10.1016/j.ipha.2023.12.001","DOIUrl":"10.1016/j.ipha.2023.12.001","url":null,"abstract":"<div><p>The plant species <em>Ziziphus mauritiana</em>, recognized by its common name Indian jujube, is classified within the Rhamnaceae family. It has been widely used in traditional medicine for its therapeutic properties, including the treatment of asthma, anxiety, depression, fever, inflammation, and ulcers. <em>Z. mauritiana</em> parts, such as leaves and fruits, have been traditionally used to treat diarrhea, wounds, abscesses, swelling, gonorrhea, liver diseases, and asthma. <em>Z. mauritiana</em> fruits are widely recognized and valued for their nutritional and nutraceutical properties and are consumed in various forms such as dried, candied, pickled, and juice. The plant exhibits antioxidant activity, and extracts from its fruits, leaves, and seeds have shown promising results in terms of their antioxidant and anticancer activities. Phytochemical studies have identified various compounds in <em>Z. mauritiana</em>, including cyclopeptide alkaloids and lupane and ceanothane triterpenes. This review presents a comprehensive overview of the ethnobotanical uses, traditional medicinal uses, and phytochemical profile of <em>Z. mauritiana</em>, highlighting its potential as a valuable medicinal plant. Further research is warranted to explore its therapeutic potential and develop new pharmaceutical applications based on its bioactive compounds.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 2","pages":"Pages 274-283"},"PeriodicalIF":0.0,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23001272/pdfft?md5=1c690ce8c653b1ffcaea22e8b5b5125b&pid=1-s2.0-S2949866X23001272-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138991181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular docking studies of some benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors: In silico design, MD simulation, pharmacokinetics and DFT studies 作为 VEGFR-2 靶点抑制剂的一些苯并恶唑和苯并噻唑衍生物的分子对接研究:硅学设计、MD 模拟、药代动力学和 DFT 研究
Pub Date : 2023-12-03 DOI: 10.1016/j.ipha.2023.11.010
Sagiru Hamza Abdullahi , Abu Tayab Moin , Adamu Uzairu , Abdullahi Bello Umar , Muhammad Tukur Ibrahim , Mustapha Tijjani Usman , Nafisa Nawal , Imren Bayil , Talha Zubair

Breast cancer, a deadly disease among women, demands effective interventions due to its global impact, with over one million annual cases. Current anti-breast cancer drugs displays several side effects, also most patients resists to these drugs during early treatment stage. Hence, global search for better drugs with less side effects became necessary. The objective of this study is to identify potential inhibitors of vascular endothelial growth factor receptor-2 (VEGFR-2), a critical target in breast cancer treatment. Molecular docking-based virtual screening of 45 benzoxazole/thiazole derivatives was conducted, followed by molecular dynamics simulations to explore ligand-protein interactions. Seven ligands (compounds 7, 10, 12, 13, 14, 20, and 26) demonstrated superior binding affinities ranging from −157.85 to −173.88 ​kcal/mol (MolDock scores) and −109.96 to −129.23 ​kcal/mol (Re-rank scores) compared to Sorafenib (−156.35 ​kcal/mol MolDock score and −102.63 ​kcal/mol Re-rank score). Compound 7, identified as a potential hit, exhibited stability in a 100-ns dynamic simulation. It was chosen as a template for designing novel inhibitors, resulting in five compounds with improved binding affinities ranging from −177.84 to −184.69 ​kcal/mol (MolDock scores) and −137.34 to −143.44 ​kcal/mol (Re-rank scores). Pharmacological profiling confirmed the drug-like properties of both the potential hit molecules and the designed compounds, with 0–1 violations against Lipinski's rule of five and favorable pharmacokinetics status. Density functional theory (DFT) studies illustrated the reactive nature of the designed compounds. These findings suggest the potential of these molecules as novel VEGFR-2 inhibitors for breast cancer treatment, providing promising prospects for future drug development.

乳腺癌是一种致命的女性疾病,每年发病人数超过 100 万,因此需要采取有效的干预措施。目前的抗乳腺癌药物有多种副作用,而且大多数患者在早期治疗阶段对这些药物产生抗药性。因此,有必要在全球范围内寻找副作用更小的更好药物。本研究的目的是找出潜在的血管内皮生长因子受体-2(VEGFR-2)抑制剂,它是乳腺癌治疗的关键靶点。研究人员对 45 种苯并恶唑/噻唑衍生物进行了基于分子对接的虚拟筛选,随后进行了分子动力学模拟,以探索配体与蛋白质之间的相互作用。与索拉非尼(-156.35 kcal/mol MolDock score和-102.63 kcal/mol Re-rank score)相比,7种配体(化合物7、10、12、13、14、20和26)表现出更优越的结合亲和力,范围在-157.85至-173.88 kcal/mol(MolDock score)和-109.96至-129.23 kcal/mol(Re-rank score)之间。被确定为潜在靶点的化合物 7 在 100-ns 动态模拟中表现出稳定性。该化合物被选为设计新型抑制剂的模板,最终产生了五种化合物,其结合亲和力得到了改善,范围从 -177.84 到 -184.69 kcal/mol(MolDock 得分)和 -137.34 到 -143.44 kcal/mol(Re-rank 得分)。药理分析证实,潜在的命中分子和设计化合物都具有类似药物的特性,违反利宾斯基五项规则的情况为 0-1 次,药代动力学状况良好。密度泛函理论(DFT)研究表明了所设计化合物的反应性质。这些发现表明,这些分子有可能成为治疗乳腺癌的新型 VEGFR-2 抑制剂,为未来的药物开发提供了广阔的前景。
{"title":"Molecular docking studies of some benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors: In silico design, MD simulation, pharmacokinetics and DFT studies","authors":"Sagiru Hamza Abdullahi ,&nbsp;Abu Tayab Moin ,&nbsp;Adamu Uzairu ,&nbsp;Abdullahi Bello Umar ,&nbsp;Muhammad Tukur Ibrahim ,&nbsp;Mustapha Tijjani Usman ,&nbsp;Nafisa Nawal ,&nbsp;Imren Bayil ,&nbsp;Talha Zubair","doi":"10.1016/j.ipha.2023.11.010","DOIUrl":"10.1016/j.ipha.2023.11.010","url":null,"abstract":"<div><p>Breast cancer, a deadly disease among women, demands effective interventions due to its global impact, with over one million annual cases. Current anti-breast cancer drugs displays several side effects, also most patients resists to these drugs during early treatment stage. Hence, global search for better drugs with less side effects became necessary. The objective of this study is to identify potential inhibitors of vascular endothelial growth factor receptor-2 (VEGFR-2), a critical target in breast cancer treatment. Molecular docking-based virtual screening of 45 benzoxazole/thiazole derivatives was conducted, followed by molecular dynamics simulations to explore ligand-protein interactions. Seven ligands (compounds 7, 10, 12, 13, 14, 20, and 26) demonstrated superior binding affinities ranging from −157.85 to −173.88 ​kcal/mol (MolDock scores) and −109.96 to −129.23 ​kcal/mol (Re-rank scores) compared to Sorafenib (−156.35 ​kcal/mol MolDock score and −102.63 ​kcal/mol Re-rank score). Compound 7, identified as a potential hit, exhibited stability in a 100-ns dynamic simulation. It was chosen as a template for designing novel inhibitors, resulting in five compounds with improved binding affinities ranging from −177.84 to −184.69 ​kcal/mol (MolDock scores) and −137.34 to −143.44 ​kcal/mol (Re-rank scores). Pharmacological profiling confirmed the drug-like properties of both the potential hit molecules and the designed compounds, with 0–1 violations against Lipinski's rule of five and favorable pharmacokinetics status. Density functional theory (DFT) studies illustrated the reactive nature of the designed compounds. These findings suggest the potential of these molecules as novel VEGFR-2 inhibitors for breast cancer treatment, providing promising prospects for future drug development.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 2","pages":"Pages 232-250"},"PeriodicalIF":0.0,"publicationDate":"2023-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23001247/pdfft?md5=deba183193dcd5333b7237f57dbc3641&pid=1-s2.0-S2949866X23001247-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138614545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A green alternative: Evaluation of Solanum torvum (Sw.) leaf extract for control of Aedes aegypti (L.) and its molecular docking potential 绿色替代品:评估 Solanum torvum (Sw.) 叶提取物防治埃及伊蚊的效果及其分子对接潜力
Pub Date : 2023-11-30 DOI: 10.1016/j.ipha.2023.11.012
R. Murugesan, K. Vasuki, B. Kaleeswaran

Due to the unavailability of effective vaccines and treatments, mosquito-borne diseases continue to pose a threat to global public health. Insecticide-treated mosquito nets and room sprays have both been successfully treated with plant-based biopesticides to protect people from mosquito bites. The extensive use of chemical pesticides is known to cause serious harm to human and animal health. From this point of view, the demand for plant extracts has recently increased worldwide. The aim of the current study was to determine the effectiveness of a Solanum torvum (Sw.) leaf extract as a larvicidal, adulticidal and in silico study against the mosquito Aedes aegypti. The plant extract from S. torvum was obtained using a simple method. Preliminary qualitative analysis shows the presence of steroids, saponins, phenol, flavonoids, tannins, and anthraquinones in the aqueous leaf extract of S. torvum. A total, 15 compounds were identified using GC–MS. The larvicidal activity, observed during 24-h and 48-h exposure cycles of 4th instar larvae, exhibits a maximum (100 ​%) mortality rate at 200 ​μg/ml. The adulticidal activity, observed during the 24-h exposure cycle of adult mosquitoes, exhibits a maximum (92 ​%) mortality rate at 2 ​mg/mL. The molecular docking observation of Protease Sterol Carrier Protein-2 (IPZ4) was noted campesterol had the most favourable docking score with a value of −10. This finding suggests that campesterol may have a high affinity for the target molecule under study. Based on the results, the current study suggests that the use of S. torvum leaf extract could serve as an environmentally friendly alternative to chemical insecticides in controlling mosquito populations and controlling mosquito bone diseases.

由于缺乏有效的疫苗和治疗方法,蚊子传播的疾病继续对全球公共卫生构成威胁。经过杀虫剂处理的蚊帐和室内喷雾剂都已成功使用植物性生物杀虫剂来保护人们免受蚊虫叮咬。众所周知,化学杀虫剂的广泛使用会对人类和动物的健康造成严重危害。因此,近来全球对植物提取物的需求有所增加。本研究的目的是确定 Solanum torvum (Sw.) 叶提取物对埃及伊蚊的杀幼虫、杀成虫效果,并对其进行硅学研究。S. torvum 的植物提取物是用一种简单的方法获得的。初步定性分析显示,S. torvum 的水性叶提取物中含有类固醇、皂苷、酚、黄酮、单宁和蒽醌。使用气相色谱-质谱(GC-MS)共鉴定出 15 种化合物。在 4龄幼虫的 24 小时和 48 小时暴露周期内观察到的杀幼虫活性显示,200 μg/ml 时死亡率最高(100%)。在成蚊的 24 小时接触周期内观察到的杀成蚊活性显示,2 毫克/毫升时的死亡率最高(92%)。对蛋白酶甾醇载体蛋白-2(IPZ4)的分子对接观察发现,坎培酯醇的对接得分最高,为-10。这一发现表明,坎培酯醇可能与所研究的目标分子具有很高的亲和力。根据这些结果,目前的研究表明,在控制蚊子数量和防治蚊子骨病方面,使用 S. torvum 叶提取物可作为化学杀虫剂的环保型替代品。
{"title":"A green alternative: Evaluation of Solanum torvum (Sw.) leaf extract for control of Aedes aegypti (L.) and its molecular docking potential","authors":"R. Murugesan,&nbsp;K. Vasuki,&nbsp;B. Kaleeswaran","doi":"10.1016/j.ipha.2023.11.012","DOIUrl":"10.1016/j.ipha.2023.11.012","url":null,"abstract":"<div><p>Due to the unavailability of effective vaccines and treatments, mosquito-borne diseases continue to pose a threat to global public health. Insecticide-treated mosquito nets and room sprays have both been successfully treated with plant-based biopesticides to protect people from mosquito bites. The extensive use of chemical pesticides is known to cause serious harm to human and animal health. From this point of view, the demand for plant extracts has recently increased worldwide. The aim of the current study was to determine the effectiveness of a <em>Solanum torvum</em> (Sw.) leaf extract as a larvicidal, adulticidal and <em>in silico</em> study against the mosquito <em>Aedes aegypti</em>. The plant extract from <em>S. torvum</em> was obtained using a simple method. Preliminary qualitative analysis shows the presence of steroids, saponins, phenol, flavonoids, tannins, and anthraquinones in the aqueous leaf extract of <em>S. torvum</em>. A total, 15 compounds were identified using GC–MS. The larvicidal activity, observed during 24-h and 48-h exposure cycles of 4<sup>th</sup> instar larvae, exhibits a maximum (100 ​%) mortality rate at 200 ​μg/ml. The adulticidal activity, observed during the 24-h exposure cycle of adult mosquitoes, exhibits a maximum (92 ​%) mortality rate at 2 ​mg/mL. The molecular docking observation of Protease Sterol Carrier Protein-2 (IPZ4) was noted campesterol had the most favourable docking score with a value of −10. This finding suggests that campesterol may have a high affinity for the target molecule under study. Based on the results, the current study suggests that the use of <em>S. torvum</em> leaf extract could serve as an environmentally friendly alternative to chemical insecticides in controlling mosquito populations and controlling mosquito bone diseases.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 2","pages":"Pages 251-262"},"PeriodicalIF":0.0,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23001260/pdfft?md5=1129f2c43cd836de384217ab5d76f41d&pid=1-s2.0-S2949866X23001260-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139299272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Towards designing of some potential new autoimmune disorder inhibitors using crystal structures and Hirshfeld surface analyses in combination with molecular docking and molecular dynamics simulations 利用晶体结构和 Hirshfeld 表面分析,结合分子对接和分子动力学模拟,设计一些潜在的新型自身免疫性疾病抑制剂
Pub Date : 2023-11-29 DOI: 10.1016/j.ipha.2023.11.008
Emmanuel Israel Edache , Adamu Uzairu , Paul Andrew Mamza , Gideon Adamu Shallangwa , Muhammad Tukur Ibrahim

The emergence of multi-drug-resistant autoimmune diseases poses a significant risk to human health and has garnered global attention. In this study, metformin and sulfasalazine have been used as starting materials or control. This research has successfully designed a hundred compounds, to assess their efficacy against two autoimmune disease pathogens: type 1 diabetes and rheumatoid arthritis. The DFT method was engaged to calculate the vibrational frequencies and Frontier Molecular orbitals (FMOs) of the selected compounds. The reactivity and selectivity of the selected compounds are analyzed using parameters like MEP and global reactivity descriptors, which are calculated and interpreted. The Density of state (DOS) of the molecule has been plotted and interpreted. Furthermore, docking results showed favorable interactions of the designed compound D385 with catalytically important amino acid residues. The interactions of the best active D385 when compared with the template and the standard drugs show similar binding sites. DFT studies further confirm the presence of HOMO orbital centered on the isoxazole ring further highlighting its importance for receptor-ligand hydrogen and hydrophobic interactions. The molecular dynamics simulations and MM/GBSA analysis reveal that the inhibitory nature of the designed compound D385 is a proven inhibitor of diabetes type 1 and rheumatoid arthritis inhibitor activities. Our study suggested that the designed compounds showed comparable results to that of metformin and sulfasalazine and may be used for further experimental studies. It can also be used as a pipeline to search for and design new potential autoimmune disease inhibitors. The most promising candidates from computational trials can be examined in a wet laboratory experiment before moving on to clinical trials.

多重耐药性自身免疫性疾病的出现对人类健康构成重大威胁,已引起全球关注。在这项研究中,二甲双胍和柳氮磺胺吡啶被用作起始材料或对照。这项研究成功设计了一百种化合物,以评估它们对两种自身免疫性疾病病原体(1 型糖尿病和类风湿性关节炎)的疗效。采用 DFT 方法计算了所选化合物的振动频率和前沿分子轨道(FMO)。通过计算和解释 MEP 和全局反应性描述符等参数,分析了所选化合物的反应性和选择性。绘制并解释了分子的状态密度(DOS)。此外,对接结果表明,所设计的化合物 D385 与具有重要催化作用的氨基酸残基具有良好的相互作用。最佳活性 D385 与模板和标准药物的相互作用显示出相似的结合位点。DFT 研究进一步证实了以异噁唑环为中心的 HOMO 轨道的存在,进一步突出了其在受体-配体氢键和疏水相互作用中的重要性。分子动力学模拟和 MM/GBSA 分析表明,所设计的化合物 D385 具有抑制 1 型糖尿病和类风湿性关节炎的活性。我们的研究表明,所设计的化合物与二甲双胍和柳氮磺胺吡啶的效果相当,可用于进一步的实验研究。它还可用作寻找和设计新的潜在自身免疫性疾病抑制剂的管道。计算试验中最有希望的候选化合物可在湿实验室实验中进行检验,然后再进入临床试验。
{"title":"Towards designing of some potential new autoimmune disorder inhibitors using crystal structures and Hirshfeld surface analyses in combination with molecular docking and molecular dynamics simulations","authors":"Emmanuel Israel Edache ,&nbsp;Adamu Uzairu ,&nbsp;Paul Andrew Mamza ,&nbsp;Gideon Adamu Shallangwa ,&nbsp;Muhammad Tukur Ibrahim","doi":"10.1016/j.ipha.2023.11.008","DOIUrl":"10.1016/j.ipha.2023.11.008","url":null,"abstract":"<div><p>The emergence of multi-drug-resistant autoimmune diseases poses a significant risk to human health and has garnered global attention. In this study, metformin and sulfasalazine have been used as starting materials or control. This research has successfully designed a hundred compounds, to assess their efficacy against two autoimmune disease pathogens: type 1 diabetes and rheumatoid arthritis. The DFT method was engaged to calculate the vibrational frequencies and Frontier Molecular orbitals (FMOs) of the selected compounds. The reactivity and selectivity of the selected compounds are analyzed using parameters like MEP and global reactivity descriptors, which are calculated and interpreted. The Density of state (DOS) of the molecule has been plotted and interpreted. Furthermore, docking results showed favorable interactions of the designed compound D385 with catalytically important amino acid residues. The interactions of the best active D385 when compared with the template and the standard drugs show similar binding sites. DFT studies further confirm the presence of HOMO orbital centered on the isoxazole ring further highlighting its importance for receptor-ligand hydrogen and hydrophobic interactions. The molecular dynamics simulations and MM/GBSA analysis reveal that the inhibitory nature of the designed compound D385 is a proven inhibitor of diabetes type 1 and rheumatoid arthritis inhibitor activities. Our study suggested that the designed compounds showed comparable results to that of metformin and sulfasalazine and may be used for further experimental studies. It can also be used as a pipeline to search for and design new potential autoimmune disease inhibitors. The most promising candidates from computational trials can be examined in a wet laboratory experiment before moving on to clinical trials.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 2","pages":"Pages 204-225"},"PeriodicalIF":0.0,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23001223/pdfft?md5=b31200ee4b0f1ad99e7cfdc235da0ce0&pid=1-s2.0-S2949866X23001223-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139297599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Intelligent Pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1